Vireo Growth Inc. Announces Fourth Quarter 2025 Results

Q4 GAAP revenue of $104.5 million increased 317.7% year-over-year, driven by recently closed M&A transactionsOn a pro forma basis, Q4 same ...

Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2025, provided full-year ...
The Manila Times

GPGI Reports Strong Fourth Quarter with Organic Revenue Growth of 17%, Net Income Growth of 189%, and Pro Forma Adjusted EBITDA Growth of 41%

Guidance for Non-GAAP Pro Forma Adjusted EBITDA includes payment of the Resolute Holdings management fee. Pro Forma Adj. Net Sales of $2,183 to $2,228 million Pro Forma Adj. EBITDA of $620 to $650 ...

GPGI, Inc.: GPGI Reports Strong Fourth Quarter with Organic Revenue Growth of 17%, Net Income Growth of 189%, and Pro Forma Adjusted EBITDA Growth of 41%

Fourth Quarter 2025Results compared to prior year period unless otherwise noted; does not include results for Husky Technologies Non-GAAP Net Sales of $118 million, up 17%GAAP Net Income of $43 millio ...